What is Theragenics Scaled Net Operating Assets?
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Theragenics's operating assets for the quarter that ended in Jun. 2013 was €52.76 Mil. Theragenics's operating liabilities for the quarter that ended in Jun. 2013 was €5.49 Mil. Theragenics's Total Assets for the quarter that ended in Mar. 2013 was €81.16 Mil. Therefore, Theragenics's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2013 was 0.58.
Theragenics Scaled Net Operating Assets Historical Data
The historical data trend for Theragenics's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theragenics Scaled Net Operating Assets Chart
|
Theragenics Annual Data
|
|
Trend |
Dec03 |
Dec04 |
Dec05 |
Dec06 |
Dec07 |
Dec08 |
Dec09 |
Dec10 |
Dec11 |
Dec12 |
| Scaled Net Operating Assets |
|
Get a 7-Day Free Trial
|
|
|
0.47 |
0.51 |
0.63 |
0.58 |
0.55 |
|
Theragenics Quarterly Data
|
|
Sep08 |
Dec08 |
Mar09 |
Jun09 |
Sep09 |
Dec09 |
Mar10 |
Jun10 |
Sep10 |
Dec10 |
Mar11 |
Jun11 |
Sep11 |
Dec11 |
Mar12 |
Jun12 |
Sep12 |
Dec12 |
Mar13 |
Jun13 |
| Scaled Net Operating Assets |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
0.61 |
0.55 |
0.59 |
0.62 |
0.58 |
Competitive Comparison of Theragenics's Scaled Net Operating Assets
For the Medical Devices subindustry, Theragenics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Theragenics's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Theragenics's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Theragenics's Scaled Net Operating Assets falls into.
Theragenics Scaled Net Operating Assets Calculation
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Theragenics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2012 is calculated as
| Scaled Net Operating Assets (SNOA) | | (A: Dec. 2012 ) |
| = | (Operating Assets (A: Dec. 2012 ) | - | Operating Liabilities (A: Dec. 2012 )) | / | Total Assets (A: Dec. 2011 ) |
| = | (53.962 | - | 5.18) | / | 88.022 |
| = | 0.55 |
where
Theragenics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2013 is calculated as
| Scaled Net Operating Assets (SNOA) | | (Q: Jun. 2013 ) |
| = | (Operating Assets (Q: Jun. 2013 ) | - | Operating Liabilities (Q: Jun. 2013 )) | / | Total Assets (Q: Mar. 2013 ) |
| = | (52.758 | - | 5.494) | / | 81.158 |
| = | 0.58 |
where
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theragenics (FRA:THX) Business Description
Traded in Other Exchanges
N/A
Address
Theragenics Corporation is a Delaware Corporation formed in 1981. It is a medical device company serving the surgical products and cancer treatment markets, operate in two business segments; the surgical products segment and the brachytherapy seed segment. The Company's surgical products business manufactures markets and sells disposable devices utilized in certain surgical procedures. Its brachytherapy seed business manufactures markets and sells radioactive 'seeds' utilized in the treatment of early stage prostate cancer. Its surgical products business was built through the acquisitions of CP Medical Corp. in May 2005, Galt Medical Corporation in August 2006, and NeedleTech Products, Inc. in July 2008. The Company manufactures almost 3,500 products in this business as part of three broad product platforms; wound closure, vascular access and specialty needles. It serves a number of markets and applications, including, among other areas, interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. With the exception of veterinary sutures, its surgical products hold relatively small market shares. Its products include both finished goods and components. The Company's products are sold mainly to original equipment manufacturers and to a network of distributors. The Company's facilities and operations are subject to extensive environmental, nuclear, regulatory and occupational health and safety laws at the federal, state and local levels. It is also subject to similar foreign laws and regulations under certain circumstances when its products are distributed outside of the United States.
Theragenics (FRA:THX) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:THX has been successfully added to your